Late Gadolinium Enhancement and Electrocardiographic Associations in Hypertrophic Cardiomyopathy
Annals of Noninvasive Electrocardiology · 2025
DOI: 10.1111/anec.70077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Noninvasive Electrocardiology, 2025. Verfasst von Issa Asfour und 9 weiteren Autor:innen. Beteiligte Einrichtung: East Tennessee State University, Johnson City, Tennessee, USA. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Electrocardiography, Gadolinium, Contrast Media. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Late gadolinium enhancement (LGE) on cardiovascular magnetic resonance (CMR) imaging is a well‐established indicator of myocardial fibrosis in hypertrophic cardiomyopathy (HCM). However, its association with electrocardiographic (ECG) abnormalities and the risk of atrial fibrillation (AF) remains uncertain.
Objectives
To investigate the association between the presence and burden of LGE with ECG characteristics, including precordial voltage, depolarization and repolarization abnormalities, and the incidence of AF in adults with HCM.
Methods
We conducted a retrospective cohort study of 144 adults with HCM with CMR and 12‐lead ECG within 30 days of each other. LGE was quantified as a percentage of LV mass and categorized as absent, < 5%, or ≥ 5%. ECG parameters, including QRS voltage, repolarization abnormalities, and LVH criteria, were analyzed. Incident AF was assessed during a median follow‐up of 6.6 years.
Results
LGE was present in 96 (67%) patients, with 21 (22%) having ≥ 5% LGE. There were no significant differences in precordial voltage between patients with and without LGE across Sokolow‐Lyon, Cornell, and Romhilt‐Estes criteria. However, T‐wave inversion was more common in leads I (41% vs. 19%, p = 0.009), aVL (50% vs. 31%, p = 0.033), and V4 (41% vs. 23%, p = 0.035) in patients with LGE. Patients with ≥ 5% LGE had a significantly lower median LVEF (64% vs. 74%, p = 0.003). Additionally, LGE presence was not associated with an increased risk of incident AF (HR 1.8, 95% CI 0.6–5.3, p = 0.308).
Conclusion
In contrast to pediatric HCM, LGE is associated with specific ECG repolarization abnormalities, particularly T‐wave inversion in lateral leads, but does not significantly affect precordial voltage in adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- East Tennessee State University, Johnson City, Tennessee, USA.
- Mayo Clinic, Rochester, Minnesota, USA.
- William Harvey Research Institute, Barts Biomedical Centre, Queen Mary University London, London, UK.
- University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Center for Inherited Cardiovascular Diseases, WellSpan Health, York, PA, USA.
- Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
ORCID-Profile: Shahid Karim, Anwar Chahal, Akil A Sherif
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
- NIH HHS
- National Institutes of Health
- National Center for Advancing Translational Sciences
Zitieren
APA
Asfour, I., Karim, S., Tabraiz, S. A., Chahal, A., Khanji, M. Y., Sherif, A. A., Ommen, S. R., Somers, V. K., Lin, G., & Brady, P. A. (2025). Late Gadolinium Enhancement and Electrocardiographic Associations in Hypertrophic Cardiomyopathy. Annals of Noninvasive Electrocardiology. https://doi.org/10.1111/anec.70077
Vancouver
Asfour I, Karim S, Tabraiz SA, Chahal A, Khanji MY, Sherif AA, et al. Late Gadolinium Enhancement and Electrocardiographic Associations in Hypertrophic Cardiomyopathy. Annals of Noninvasive Electrocardiology. 2025. doi:10.1111/anec.70077
BibTeX
@article{Asfour2025,
author = {Asfour, Issa and Karim, Shahid and Tabraiz, Sair A and Chahal, Anwar and Khanji, Mohammed Y and Sherif, Akil A and Ommen, Steve R and Somers, Virend K and Lin, Grace and Brady, Peter A},
title = {Late Gadolinium Enhancement and Electrocardiographic Associations in Hypertrophic Cardiomyopathy},
journal = {Annals of Noninvasive Electrocardiology},
year = {2025},
doi = {10.1111/anec.70077}
}
EUVIMED